Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors
Condition(s):Nectin4-positive Advanced Malignant Solid TumorLast Updated:November 18, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):Nectin4-positive Advanced Malignant Solid TumorLast Updated:November 18, 2020Recruiting
Condition(s):Advanced Solid TumoursLast Updated:June 13, 2022Active, not recruiting
Condition(s):Solid Tumor, AdultLast Updated:August 20, 2019Unknown status
Condition(s):Solid TumorLast Updated:February 25, 2022Recruiting
Condition(s):Prostate Cancer; Colon CancerLast Updated:June 12, 2014Completed
Condition(s):Pediatric Solid TumorsLast Updated:February 26, 2021Recruiting
Condition(s):Osteosarcoma; Ewing Sarcoma; Rhabdomyosarcoma; Relapsed Pediatric Solid Tumor; Refractory Pediatric Solid Tumor; Melanoma; Hepatoblastoma; Hepatocellular Carcinoma; Neuroblastoma; Wilms TumorLast Updated:March 31, 2022Recruiting
Condition(s):Nonsmall Cell Lung Cancer; Solid Tumor, AdultLast Updated:September 24, 2021Recruiting
Condition(s):Advanced Solid TumorLast Updated:February 18, 2022Recruiting
Condition(s):Advanced Solid TumorLast Updated:April 29, 2019Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.